These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 26209866)
1. Vitamin D Deficiency among Adolescent Females with Polycystic Ovary Syndrome. Sadhir M; Kansra AR; Menon S J Pediatr Adolesc Gynecol; 2015 Oct; 28(5):378-81. PubMed ID: 26209866 [TBL] [Abstract][Full Text] [Related]
2. Serum 25-Hydroxy Vitamin D Levels in Turkish Adolescent Girls with Polycystic Ovary Syndrome and the Correlation with Clinical/Biochemical Parameters. Bostanci EI; Ozler S; Yilmaz NK; Yesilyurt H J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):270-273. PubMed ID: 28782659 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China. Wang L; Lv S; Li F; Yu X; Bai E; Yang X Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394 [No Abstract] [Full Text] [Related]
4. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients. Karadağ C; Yoldemir T; Yavuz DG J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433 [TBL] [Abstract][Full Text] [Related]
5. Low vitamin D3 and high anti-Müllerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link? Cappy H; Giacobini P; Pigny P; Bruyneel A; Leroy-Billiard M; Dewailly D; Catteau-Jonard S Ann Endocrinol (Paris); 2016 Oct; 77(5):593-599. PubMed ID: 26997468 [TBL] [Abstract][Full Text] [Related]
6. The association between anti-Müllerian hormone and vitamin 25(OH)D serum levels and polycystic ovarian syndrome in adolescent females. Simpson S; Seifer DB; Shabanova V; Lynn AY; Howe C; Rowe E; Caprio S; Vash-Margita A Reprod Biol Endocrinol; 2020 Nov; 18(1):118. PubMed ID: 33218348 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D levels and lipid profiles in patients with polycystic ovary syndrome. Moieni A; Haghollahi F; Dashtkoohi M; Abiri A; Salari E; Najafi MS; Tajik N BMC Womens Health; 2024 Aug; 24(1):472. PubMed ID: 39192256 [TBL] [Abstract][Full Text] [Related]
8. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance. Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987 [TBL] [Abstract][Full Text] [Related]
9. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome. Ng BK; Lee CL; Lim PS; Othman H; Ismail NAM Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28586302 [TBL] [Abstract][Full Text] [Related]
11. 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome. Güdücü N; Görmüş U; Kutay SS; Kavak ZN; Dünder I Gynecol Endocrinol; 2014 Aug; 30(8):557-60. PubMed ID: 24819314 [TBL] [Abstract][Full Text] [Related]
12. Serum Vitamin D Binding Protein Level Associated with Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome. Kuliczkowska-Plaksej J; Pasquali R; Milewicz A; Lwow F; Jedrzejuk D; Bolanowski M Horm Metab Res; 2019 Jan; 51(1):54-61. PubMed ID: 30408832 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Li HW; Brereton RE; Anderson RA; Wallace AM; Ho CK Metabolism; 2011 Oct; 60(10):1475-81. PubMed ID: 21550088 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome. Velija-Ašimi Z Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360 [TBL] [Abstract][Full Text] [Related]
15. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study. Santos BR; Lecke SB; Spritzer PM PLoS One; 2017; 12(3):e0173695. PubMed ID: 28278285 [TBL] [Abstract][Full Text] [Related]
16. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D. Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. Irani M; Minkoff H; Seifer DB; Merhi Z J Clin Endocrinol Metab; 2014 May; 99(5):E886-90. PubMed ID: 24606102 [TBL] [Abstract][Full Text] [Related]
18. Associations between vitamin D levels and polycystic ovary syndrome phenotypes. Davis EM; Peck JD; Hansen KR; Neas BR; Craig LB Minerva Endocrinol; 2019 Jun; 44(2):176-184. PubMed ID: 29652114 [TBL] [Abstract][Full Text] [Related]
19. Impact of hypovitaminosis D on clinical, hormonal and insulin sensitivity parameters in normal body mass index polycystic ovary syndrome women. Ganie MA; Marwaha RK; Nisar S; Farooqi KJ; Jan RA; Wani SA; Gojwari T; Shah ZA J Obstet Gynaecol; 2016 May; 36(4):508-12. PubMed ID: 26772667 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities. Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]